文献速递头颈部肿瘤放疗

基于深度学习识别II期鼻咽癌单纯调强放疗最佳候选者的预后与预测模型:一项回顾性多中心研究

A prognostic and predictive model based on deep learning to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma: A retrospective multicenter study.
PubMed 文献 · Radiother Oncol · 2024-12-05

该多中心回顾性研究纳入两中心999例II期鼻咽癌患者,利用3DResNet提取MRI深度学习特征并结合临床信息构建XGBoost模型,按总体评分最佳截断值分层为高危和低危组。联合模型在训练、内部验证和外部测试队列的C-index分别为0.789、0.768和0.804,显著优于MRI模型、T分期和N分期。总体评分<0.405与低进展风险显著相关,低危组中单纯IMRT患者的无进展生存期与接受额外化疗者相当甚至更优。

要点

  • 联合模型在训练、内部验证和外部测试队列的C-index分别为0.789、0.768和0.804。
  • 总体评分<0.405与低进展风险显著相关。
  • 低危组中单纯IMRT的无进展生存期与额外化疗相当甚至更优。

核心结论

  • 模型对无进展生存期表现出满意的预后与预测性能。
  • II期鼻咽癌患者被分层为不同风险组,有助于识别可从单纯IMRT中获益的最佳候选者。

研究设计与样本

  • 多中心回顾性研究,纳入两中心999例II期鼻咽癌患者。
  • 采用3DResNet提取MRI深度学习特征,使用eXtreme Gradient Boosting模型整合预训练特征与临床信息获得每例患者的总体评分。
  • 根据总体评分最佳截断值将患者分层为高危组和低危组。
  • 使用一致性指数、曲线下面积值和校准检验评估模型性能,用生存曲线分析各风险组额外化疗的临床获益。

主要发现

  • 联合模型在训练队列的C-index为0.789(95%CI 0.787-0.791),在内部验证队列为0.768(95%CI 0.764-0.771),在外部测试队列为0.804(95%CI 0.801-0.807)。
  • 联合模型相比MRI模型、T分期和N分期显示出统计学显著改善。
  • 总体评分<0.405与低进展风险显著相关。
  • 低危组中,单纯IMRT患者的无进展生存期与接受额外化疗者相当甚至更优。

关键数值与推荐

  • 联合模型训练队列C-index 0.789(95%CI 0.787-0.791)。
  • 联合模型内部验证队列C-index 0.768(95%CI 0.764-0.771)。
  • 联合模型外部测试队列C-index 0.804(95%CI 0.801-0.807)。
  • 总体评分<0.405与低进展风险显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop and validate a prognostic and predictive model integrating deep learning MRI features and clinical information in patients with stage II nasopharyngeal carcinoma (NPC) to identify patients with a low risk of progression for whom intensity-modulated radiotherapy (IMRT) alone is sufficient. METHODS: This multicenter, retrospective study enrolled 999 patients with stage II NPC from two centers. 3DResNet was used to extract deep learning MRI features and eXtreme Gradient Boosting model was employed to integrate the pre-trained features and clinical information to obtain an overall score for each patient. Based on the optimal cutoff value of the overall score, patients were stratified into high- and low- risk groups. Model performance was evaluated using concordance indexes (C-indexes), the area under the curve (AUC) values and calibration tests. Survival curves were used to analyze the clinical benefits of additional chemotherapy in each risk group. RESULTS: The combined model achieved a concordance index of 0.789 (95 % confidence interval [CI] 0.787-0.791), 0.768 (95 % CI 0.764-0.771), and 0.804 (95 % CI 0.801-0.807) for the training, internal validation, and external test cohorts, respectively, demonstrating a statistically significant improvement compared to the MRI model, T Stage, and N Stage. An overall score of < 0.405 in patients was significantly associated with a low risk of progression. In the low-risk group, patients treated with IMRT alone had comparable or even superior progression-free survival (PFS) compared to those who received additional chemotherapy. CONCLUSION: The model demonstrated a satisfactory prognostic and predictive performance for PFS. Patients with stage II NPC were stratified into different risk groups to help identify optimal candidates who could benefit from IMRT alone.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Liang JL, Wen YF, Huang YP, et al. A prognostic and predictive model based on deep learning to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma: A retrospective multicenter study. Radiother Oncol. 2024. PMID: 39645201. doi:10.1016/j.radonc.2024.110660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。